NCT05998850Completed
Dialysis CHW Pilot
Community Health Worker Navigation of Community Resources for Dialysis Patients: A Pilot Intervention
Source: ClinicalTrials.gov · Last updated 30 Mar 2025
Brief summary (registry, in English)
To determine the acceptability and feasibility of a community health worker intervention that assists dialysis patients with low socioeconomic status navigate community resources to address health-related social needs. Findings will be used for a future randomized trial that determines the efficacy of the CHW intervention on mental health, quality of life, addressing social needs, and clinical outcomes. This study is intended to be generalizable in all dialysis centers.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 19 Jul 2023
- Start date
- 1 Oct 2023
- Primary completion date
- 31 Oct 2024
- Lead sponsor
- University of Texas at Austin
- Diseases
- Chronic kidney disease
- NCT number
- NCT05998850
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Oct 2023 to the primary completion date, 31 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Live in a nursing facility or institution
- Physically or mentally unable or unwilling to participate
Who the study is looking for
- Have kidney failure and be receiving dialysis
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas at Austin Coordinator of this site? Confirm its status | Austin | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.